Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management, is a transformative document that will shape global regulatory submissions and practices.
Watch Now
Bio Pharma Asia
Companies often experience regulatory challenges during an inspection of aging facilities, requiring them to initiate projects to optimize product protection and updating to current standards for classified areas for biopharma manufacturing. For a long time, the company response has been to improve the existing classified areas or maybe even upgrading to a higher grade of classification. However, it may be more appropriate, and improve product protection, to instead implement the use of closed system processes and downgrade room classification during these facility renovation projects. If closed systems are fully utilized, then a CNC space can be used. As well as reducing the complexity of operations, this will reduce capital and operating costs.
Watch Now
Eeuropeanpharmaceuticalreview
In this webinar, we introduce you to laboratory information management systems (LIMS) and demonstrate how this software can help you achieve regulatory compliance, quality data management throughout your product’s life cycle.
Watch Now
Systechone
Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution, and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the pharmaceutical industry. The global value of pharmaceutical counterfeiting is $200B annually. More staggering is that the gray market is forecasted to reach almost $3 trillion by 2022.
Watch Now